Baseline characteristics
| Patient characteristics | Sexually active (%), n=55 | Not sexually active (%), n=182 | P value |
| Age (median, range) (years) | 51.5 (21–74) | 61.8 (29–75) | <0.0001 |
| Performance status | 0.052 | ||
| ECOG 0 | 51 (93) | 149 (82) | |
| ECOG 1 | 4 (7) | 33 (18) | |
| Final FIGO stage | 0.33 | ||
| I–IIA | 2 (4) | 7 (4) | |
| IIB–IIIA | 14 (25) | 28 (15) | |
| III–IV | 38 (69) | 139 (76) | |
| Missing | 1 (2) | 8 (4) | |
| Randomized treatment | 0.34 | ||
| LNE | 25 (45) | 96 (53) | |
| No LNE | 30 (55) | 86 (47) | |
ECOG, Eastern Cooperative Oncology Group ; FIGO, International Federation of Gynecology and Obstetrics ; LNE, Lymphadenectomy.